CoreMedix News and Activities

Presence

CorMedix is a pharmaceutical company that develops and sells anti-infective therapies for critical care. Its products focus on catheter infection prevention for hospitals, dialysis providers, and other healthcare customers.

CoreMedix products and services overview:

Anti infective drugs
Catheter care
Infection prevention
Critical care therapies

Revenue: ~$43 million

Employees: 75

Headquarters: Berkeley Heights, Canada

CoreMedix is one of the...

CoreMedix is a company listed under the stock ticker CRMD (US).

Acquisition, funding and merger involving CoreMedix.

CoreMedix has acquired Melinta Therapeutics (posted on September 3 2025).

Executives

View the org chart displaying its 21 main executives

Most searched biographies at CoreMedix

Popular executive movements at CoreMedix

Joseph Todisco who was Chief Executive Officer, becomes Chief Executive Officer and Chairman of the Board (posted on January 9 2026).
Myron Kaplan who was Chairman of the Board, becomes Lead Independent Director (posted on January 9 2026).

Create your alert
to follow the executive moves at CoreMedix.